Mark Dobson

Statistics

Publications

Citations

220

H-Index

Active since

2004

Affiliations

Tallaght University Hospital(Current)

University of Edinburgh

Technion – Israel Institute of Technology

New York Hospital Queens

The University of Melbourne

Mark Dobson is an author at Tallaght University Hospital specializing in medicine, cardiovascular disease surveillance, and helicobacter pylori infection.

Publications per year

2004–2021

Publications

Rifabutin‐ and furazolidone‐based <scp>Helicobacter pylori</scp> eradication therapies after failure of standard first‐ and second‐line eradication attempts in dyspepsia patients

Asghar Qasim, Shaji Sebastian, Orla Thornton et al. · Alimentary Pharmacology & Therapeutics · 2004 · 89 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI)

Hazel Ní Chonchubhair, Yasir Bashir, Mark Dobson et al. · Pancreatology · 2018 · 66 citations

Medicine, Clinical Sciences, Microbiology +13

Impact of COVID-19 on Cardiovascular Testing in the United States Versus the Rest of the World

Cole B. Hirschfeld, Leslee J. Shaw, Michelle A. Williams et al. · JACC. Cardiovascular imaging · 2021 · 39 citations · Full text

Medicine, Cardiology, Preventive Medicine +14

Impact of <i>Helicobacter pylori</i> on the management of dyspepsia in primary care

Kathleen Bennett, J. Feely, Orla Thornton et al. · Alimentary Pharmacology & Therapeutics · 2006 · 13 citations · Full text

Medicine, Family Medicine, Internal Medicine +13

Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia

Takashi Kudo, Ryan Lahey, Cole B. Hirschfeld et al. · JACC Asia · 2021 · 13 citations · Full text

Medicine, Cardiology, Health Sciences +12

1–5 of 5